MyHashtagDiscovery Network
Current space

Members

Filtered creator directory for "therapeutic".

Add Pin Explore Posts
Directory 201.5K Indexed posts 43M Verified 0
Active AuthorsRecent indexed creators Registered MembersAccount directory Completed ProfilesProfiles with public details VerifiedTrusted member signals
201.5KActive members
43MIndexed posts
286KDetailed profiles
26Sources in this view

Active authors

Showing directory results matching your search with real activity counts for visible profiles.

Page 1 | 25 shown
A
Aristea Therapeutics Announces Discontinuation of RIST4721 Development Program and Decision to Dissolve the Company
Aristea Therapeutics Announces Discontinuation of RIST4721 Development Program and Decision...
Aristea Therapeutics avatar
@Aristea Therapeutics
Aristea Therapeutics
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Aristea Therapeutics Announces Discontinuation of RIST4721 Development Program and Decision to Dissolve the Company
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
A
Auravax Therapeutics Announces Formation of Scientific Advisory Board Chaired by George M....
AuraVax Therapeutics Inc. avatar
@AuraVax Therapeutics Inc.
AuraVax Therapeutics
Feb 24, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Auravax Therapeutics Announces Formation of Scientific Advisory Board Chaired by George M. Church, PhD
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
B
Progenity Announces Pricing of Initial Public Offering
Progenity Announces Pricing of Initial Public Offering
Biora Therapeutics, Inc. avatar
@Biora Therapeutics, Inc.
Biora Therapeutics,
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Progenity Announces Pricing of Initial Public Offering
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
B
BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's® Phase 3 Study for ALS in Muscle and Nerve
BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's® Phase 3 Stud...
BrainStorm Cell Therapeutics Inc. avatar
@BrainStorm Cell Therapeutics Inc.
BrainStorm Cell
Mar 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's® Phase 3 Study for ALS in Muscle and Ne...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
C
Checkpoint Therapeutics Announces FDA Approval of
Checkpoint Therapeutics Announces FDA Approval of
Checkpoint Therapeutics, Inc avatar
@Checkpoint Therapeutics, Inc
Checkpoint Therapeutics,
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Checkpoint Therapeutics Announces FDA Approval of
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
C
Coya Therapeutics, Inc. Announces Peer-Reviewed Publication
Coya Therapeutics, Inc. Announces Peer-Reviewed Publication
Coya Therapeutics, Inc. avatar
@Coya Therapeutics, Inc.
Coya Therapeutics,
Feb 1, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Coya Therapeutics, Inc. Announces Peer-Reviewed Publication
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
F
Finch Therapeutics Announces Decision to Discontinue Phase
Finch Therapeutics Announces Decision to Discontinue Phase
Finch Therapeutics Group, Inc. avatar
@Finch Therapeutics Group, Inc.
Finch Therapeutics
Jan 30, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Finch Therapeutics Announces Decision to Discontinue Phase
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
F
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics avatar
@Flare Therapeutics
Flare Therapeutics
Mar 19, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
H
Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone N...
Harm Reduction Therapeutics, Inc. avatar
@Harm Reduction Therapeutics, Inc.
Harm Reduction
Feb 24, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Gr...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
I
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Ge...
Interius BioTherapeutics, Inc. avatar
@Interius BioTherapeutics, Inc.
Interius BioTherapeutics,
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
L
Lykos Therapeutics (Formerly MAPS PBC) Announces Publication Examining the Effects of MDMA-...
Lykos Therapeutics avatar
@Lykos Therapeutics
Lykos Therapeutics
Mar 20, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Lykos Therapeutics (Formerly MAPS PBC) Announces Publication Examining the Effects of MDMA-Assisted Therapy on Emotio...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
L
Lyra Therapeutics Provides Corporate Update
Lyra Therapeutics Provides Corporate Update
Lyra Therapeutics avatar
@Lyra Therapeutics
Lyra Therapeutics
Feb 1, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Lyra Therapeutics Provides Corporate Update
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
M
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to...
MediLink Therapeutics (Suzhou) Co., Ltd. avatar
@MediLink Therapeutics (Suzhou) Co., Ltd.
MediLink Therapeutics
Feb 1, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation a...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
M
Mineralys Therapeutics Closes $40 Million Series A Funding
Mineralys Therapeutics Closes $40 Million Series A Funding
Mineralys Therapeutics avatar
@Mineralys Therapeutics
Mineralys Therapeutics
Jan 29, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Mineralys Therapeutics Closes $40 Million Series A Funding
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
N
Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer
Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial...
Nektar Therapeutics avatar
@Nektar Therapeutics
Nektar Therapeutics
Feb 1, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
N
Nohla Therapeutics Announces Second Closing of $56 Million
Nohla Therapeutics Announces Second Closing of $56 Million
Nohla Therapeutics avatar
@Nohla Therapeutics
Nohla Therapeutics
Feb 6, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Nohla Therapeutics Announces Second Closing of $56 Million
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
P
PTC Therapeutics and Massachusetts General Hospital Collaborate on Rare Disease Research
PTC Therapeutics, Inc. avatar
@PTC Therapeutics, Inc.
PTC Therapeutics,
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
PTC Therapeutics and Massachusetts General Hospital Collaborate on Rare Disease Research
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
R
Rani Therapeutics Announces Pricing of Initial Public
Rani Therapeutics Announces Pricing of Initial Public
Rani Therapeutics, LLC avatar
@Rani Therapeutics, LLC
Rani Therapeutics,
Mar 30, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Rani Therapeutics Announces Pricing of Initial Public
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
R
Ridgeback Biotherapeutics LP announces licensing of mAb114, an experimental Ebola treatment, from the National Institute of Allergy and Infectious Diseases
Ridgeback Biotherapeutics LP announces licensing of mAb114, an experimental Ebola treatment...
Ridgeback Biotherapeutics LP avatar
@Ridgeback Biotherapeutics LP
Ridgeback Biotherapeutics
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Ridgeback Biotherapeutics LP announces licensing of mAb114, an experimental Ebola treatment, from the National Instit...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
S
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Applicat...
Sentynl Therapeutics avatar
@Sentynl Therapeutics
Sentynl Therapeutics
Jan 27, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper H...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
S
Silk Therapeutics Raises $6 Million In Series A2 Financing
Silk Therapeutics, Inc. avatar
@Silk Therapeutics, Inc.
Silk Therapeutics,
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Silk Therapeutics Raises $6 Million In Series A2 Financing
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
S
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurol...
Skyhawk Therapeutics avatar
@Skyhawk Therapeutics
Skyhawk Therapeutics
Feb 8, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 2Posts 2Sources 0Reputation
Latest signal 0 reactions
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
newswire.ca
0Following 0Comments 0Views 0Shares
View profile Posts
T
Home | Therapeutic Guidelines
Home | Therapeutic Guidelines
Therapeutic Guidelines avatar
@Therapeutic Guidelines
Therapeutic Guidelines
Apr 14, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Home | Therapeutic Guidelines
app.tg.org.au
0Following 0Comments 0Views 0Shares
View profile Posts
W
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Genera...
Whitehawk Therapeutics, Inc. avatar
@Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics,
Apr 19, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the...
prnewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts
W
WindMIL Therapeutics Announces FDA Clearance of
WindMIL Therapeutics Announces FDA Clearance of
WindMIL Therapeutics avatar
@WindMIL Therapeutics
WindMIL Therapeutics
Jan 29, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
WindMIL Therapeutics Announces FDA Clearance of
globenewswire.com
0Following 0Comments 0Views 0Shares
View profile Posts